American Heart Journal
Volume 149, Issue 6 , Pages 1020-1034 , June 2005

Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: Randomized trial evidence through 2004

  • Sana M. Al-Khatib, MD, MHS

      Affiliations

    • The Duke Clinical Research Institute, Durham, NC
    • Corresponding Author InformationReprint requests: Sana M. Al-Khatib, MD, Duke Clinical Research Institute, PO Box, 17969, Durham, NC 27715.
    • ,
  • Gillian D. Sanders, PhD

      Affiliations

    • The Duke Clinical Research Institute, Durham, NC
    • ,
  • Daniel B. Mark, MD, MPH

      Affiliations

    • The Duke Clinical Research Institute, Durham, NC
    • ,
  • Kerry L. Lee, PhD

      Affiliations

    • The Duke Clinical Research Institute, Durham, NC
    • ,
  • Gust H. Bardy, MD

      Affiliations

    • The Seattle Institute for Cardiac Research, Seattle, Wash
    • ,
  • J. Thomas Bigger, MD

      Affiliations

    • Columbia University, New York, NY
    • ,
  • Alfred E. Buxton, MD

      Affiliations

    • Brown Medical School, Providence, RI
    • ,
  • Stuart Connolly, MD

      Affiliations

    • Hamilton General Hospital, Hamilton, Ontario
    • ,
  • Alan Kadish, MD

      Affiliations

    • Northwestern University, Chicago, Ill
    • ,
  • Arthur Moss, MD

      Affiliations

    • University of Rochester, Rochester, NY
    • ,
  • Arthur M. Feldman, MD, PhD

      Affiliations

    • Thomas Jefferson University, Philadelphia, Pa
    • ,
  • Kenneth A. Ellenbogen, MD

      Affiliations

    • Medical College of Virginia, Richmond, Va
    • ,
  • Steven Singh, MD

      Affiliations

    • Veterans Affairs Medical Center, Washington, DC
    • ,
  • Robert M. Califf, MD

      Affiliations

    • The Duke Clinical Research Institute, Durham, NC
    • ,
  • for an expert panel participating in a Duke Clinical Research Institute-sponsored conference

Received 7 February 2005 ,Accepted 7 February 2005.

References 

  1. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med. 1996;335:1933–1940
  2. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial investigators. N Engl J Med. 1999;341:1882–1890
  3. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883
  4. Kadish A, Dyer A, Daubert JP, et al. for the Defibrillators in Non-ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators Prophylactic defibrillator implantation in patients with non-ischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151–2158
  5. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237
  6. Bristow MR, Saxon LA, Boehmer J, et al. for the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150
  7. Kass DA, Chen CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation. 1999;99:156–173
  8. Wyman BT, Hunter WC, Prinzen FW, et al. Mapping propagation of mechanical activation in the paced heart with MRI tagging. Am J Physiol. 1999;276:H881–H891
  9. Kerwin WF, Botvinick EH, O'Connell JW, et al. Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol. 2000;35:1221–1227
  10. Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation. 2000;102:3053–3059
  11. Sogaard P, Egeblad H, Kim WY, et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol. 2002;40:723–730
  12. Stellbrink C, Breithardt OA, Franke A, et al. for the PATH-CHF (PAcing THerapies in Congestive Heart Failure) Investigators Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol. 2001;38:1957–1965
  13. Breithardt OA, Stellbrink C, Franke A, et al. for the Pacing Therapies for Congestive Heart Failure Study Group Acute effects of cardiac resynchronization therapy on left ventricular Doppler indices in patients with congestive heart failure. Am Heart J. 2002;143:34–44
  14. Duncan A, Wait D, Gibson D, et al. MUSTIC (Multisite Stimulation in Cardiomyopathies) Trial. Left ventricular remodelling and haemodynamic effects of multisite biventricular pacing in patients with left ventricular systolic dysfunction and activation disturbances in sinus rhythm: sub-study of the MUSTIC (Multisite Stimulation in Cardiomyopathies) trial. Eur Heart J. 2003;24:430–441
  15. Bigger JT for the Coronary Artery Bypass Graft (CABG) Patch trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med. 1997;337:1569–1575
  16. Hohnloser SH, Connolly SJ, Kuck KH, et al. The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): study protocol. Am Heart J. 2000;140:735–739
  17. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481–2488
  18. RevMan Analyses [Computer program]. Version 1.0 for Windows. In: Review Manager (RevMan) 4.2.7 Oxford. England: The Cochrane Collaboration; 2004;
  19. DerSimonian R, Laird NM. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  20. Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med. 2000;342:1937–1945
  21. The MADIT-II Trial. In: Presented at: ACC scientific sessions, March. 2002;
  22. Chen X, Shenasa M, Borggrefe M, et al. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients. Eur Heart J. 1994;15:76–82
  23. Turitto G, Ahuja RK, Caref EB, et al. Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: role of programmed ventricular stimulation and the signal-averaged electrocardiogram. J Am Coll Cardiol. 1994;24:1523–1528
  24. Grimm W, Hoffmann J, Menz V, et al. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol. 1998;32:739–745
  25. Brilakis ES, Shen WK, Hammill SC, et al. Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope. Pacing Clin Electrophysiol. 2001;24:1623–1630
  26. Gomes JA, Cain ME, Buxton AE, et al. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation. 2001;104:436–441
  27. Kuchar DL, Thorburn CW, Sammel NL. Late potentials detected after myocardial infarction: natural history and prognostic significance. Circulation. 1986;74:1280–1289
  28. Kuchar DL, Thorburn CW, Sammel NL. Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography. J Am Coll Cardiol. 1987;9:531–538
  29. Farrell TG, Bashir Y, Cripps T, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol. 1991;18:687–697
  30. La Rovere MT, Bigger JT, Marcus FI, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998;351:478–484
  31. Hohnloser SH, Ikeda T, Bloomfield DM, et al. T-wave alternans negative coronary patients with low ejection fraction and benefit from defibrillator implantation. Lancet. 2003;362:125–126
  32. Chow T, Schloss EJ, Waller TJ, et al. Microvolt T-wave alternans identifies MADIT II type patients at low risk of ventricular tachyarrhythmic events. Circulation. 2003;109:IV–323[abstract]
  33. Bloomfield DM, Steinman RC, Namerow PB, et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy. A solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation. 2004;110:1885–1889
  34. Cohen RJ. Enhancing specificity without sacrificing sensitivity: potential benefits of using microvolt t-wave alternans testing to risk stratify the MADIT-II population. Card Electrophysiol Rev. 2003;7:438–442
  35. Adachi K, Ohnishi Y, Yokoyama M. Risk stratification for sudden cardiac death in dilated cardiomyopathy using microvolt-level T-wave alternans. Jpn Circ J. 2001;65:76–80
  36. Hennersdorf MG, Perings C, Niebch V. T wave alternans as a risk predictor in patients with cardiomyopathy and mild-to-moderate heart disease. Pacing Clin Electrophysiol. 2000;23:386–391
  37. Hohnloser SH, Klingenheben T, Bloomfield D, et al. Usefulness of microvolt t-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from prospective observational study. J Am Coll Cardiol. 2003;41:2225–2227
  38. Grimm W, Christ M, Bach J, et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg cardiomyopathy study. Circulation. 2003;108:2883–2891
  39. Rashba EJ, Osman AF, MacMurdy K, et al. Influence of QRS duration on the prognostic value of T wave alternans. J Cardiovasc Electrophysiol. 2002;13:770–775
  40. The DAVID Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA. 2002;288:3115–3123
  41. Cazeau S, Leclercq C, Lavergne T, et al. for the Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873–880
  42. Auricchio A, Stellbrink C, Sack S, et al. for the Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 2002;39:2026–2033
  43. Auricchio A, Stellbrink C, Butter C, et al. or the Pacing Therapies in Congestive Heart Failure II Study Group Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol. 2003;42:2109–2116
  44. Abraham WT, Fisher WG, Smith AL, et al. for the MIRACLE Study Group Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–1853
  45. Kuhlkamp V for the InSync 7272 ICD World Wide Investigators. Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. J Am Coll Cardiol. 2002;39:790–797
  46. Young JB, Abraham WT, Smith AL, et al. for the Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685–2694
  47. Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003;42:1454–1459
  48. Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA. 2003;289:730–740
  49. Finlay AM, Ezekowitx MB, Wiebe N, et al. Systemic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med. 2004;141:1–16
  50. Nelson GS, Curry CW, Wyman BT, et al. Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Circulation. 2000;101:2703–2709
  51. Pitzalis MV, Iacoviello M, Romito R, et al. Cardiac resynchronization therapy tailored by echocardiograph evaluation of ventricular asynchrony. J Am Coll Cardiol. 2002;40:1615–1622
  52. Fauchier L, Marie O, Casset-Sernon D, et al. Interventricular and intraventricular dyssynchrony in idiopathic dilated cardiomyopathy: a prognostic study with Fourier phase analysis of radionuclide angioscintigraphy. J Am Coll Cardiol. 2002;40:2022–2030
  53. Rueter S, Garrigue S, Barold SS, et al. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol. 2002;89:346–350
  54. Gorcsan J, Kanzaki H, Bazaz R, et al. Usefulness of echocardiographic tissue synchronization imaging to predict acute response to cardiac resynchronization therapy. Am J Cardiol. 2004;93:1178–1181
  55. Breithardt OA, Stellbrink C, Kramer AP, et al. for the PATH-CF Study Group Pacing Therapies for Congestive Heart Failure. Echocardiographic quantification of left ventricular asynchrony predicts an acute hemodynamic benefit of cardiac resynchronization therapy. J Am Coll Cardiol. 2002;40:536–545
  56. The Post AV Nodal Ablation Evaluation (PAVE) trial. In: Presented at: ACC scientific sessions, March. 2004;
  57. Leon AR, Greenberg JM, Kanuru N, et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol. 2002;39:1258–1263
  58. Leclercq C, Walker S, Linde C, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J. 2002;23:1780–1787
  59. Leclercq C, Victor F, Alonso C, et al. Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation. Am J Cardiol. 2000;85:1154–1156

 This conference was funded by the Agency for Health, Research and Quality, and the Duke Clinical Research Institute, Durham, NC.

PII: S0002-8703(05)00123-7

doi: 10.1016/j.ahj.2005.02.005

American Heart Journal
Volume 149, Issue 6 , Pages 1020-1034 , June 2005

Article Tools

* Image Usage & Resolution